1. Home
  2. WLY vs AMPH Comparison

WLY vs AMPH Comparison

Compare WLY & AMPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo John Wiley & Sons Inc.

WLY

John Wiley & Sons Inc.

HOLD

Current Price

$30.75

Market Cap

2.2B

ML Signal

HOLD

Logo Amphastar Pharmaceuticals Inc.

AMPH

Amphastar Pharmaceuticals Inc.

HOLD

Current Price

$26.75

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WLY
AMPH
Founded
1807
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Books
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.2B
1.2B
IPO Year
N/A
2014

Fundamental Metrics

Financial Performance
Metric
WLY
AMPH
Price
$30.75
$26.75
Analyst Decision
Buy
Analyst Count
0
6
Target Price
N/A
$31.00
AVG Volume (30 Days)
731.8K
375.1K
Earning Date
12-04-2025
11-06-2025
Dividend Yield
4.58%
N/A
EPS Growth
N/A
N/A
EPS
1.87
2.27
Revenue
$1,665,756,000.00
$723,305,000.00
Revenue This Year
$0.02
$1.35
Revenue Next Year
$2.32
$5.10
P/E Ratio
$16.58
$11.91
Revenue Growth
N/A
N/A
52 Week Low
$29.93
$20.39
52 Week High
$47.26
$39.01

Technical Indicators

Market Signals
Indicator
WLY
AMPH
Relative Strength Index (RSI) 34.76 53.43
Support Level $30.52 $26.26
Resistance Level $31.53 $27.23
Average True Range (ATR) 0.79 0.74
MACD 0.11 0.05
Stochastic Oscillator 26.38 75.44

Price Performance

Historical Comparison
WLY
AMPH

About WLY John Wiley & Sons Inc.

John Wiley & Sons Inc is one of the world's greatest publishers and a trusted leader in research and learning. Its industry-principal content, services, platforms, and knowledge networks are tailored to meet the evolving needs of its customers and partners, including researchers, students, instructors, professionals, institutions, and corporations. The company empowers knowledge-seekers to transform today's obstacles into tomorrow's brightest opportunities. For more than two centuries, the company has been delivering on its timeless mission to unlock human potential.

About AMPH Amphastar Pharmaceuticals Inc.

Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient, or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has one reportable segment pharmaceutical products. Geographically the business presence of the firm is seen in the United States, China and France of which the U.S. accounts for the majority of the revenue.

Share on Social Networks: